A recent legal decision could signal the ultimate demise of the FTC’s final rule banning most noncompete clauses. A biotech ...

Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.

Interius BioTherapeutics has received approval to begin a Phase I trial in Australia of an investigational in vivo CAR-T ...

Preliminary data from a late-stage trial of Alnylam’s RNAi therapy for ATTR amyloidosis with cardiomyopathy appear strong, ...

The regulator Tuesday added atopic dermatitis to the label of Arcutis Biotherapeutics’ topical PDE4 inhibitor Zoryve for the ...

Artificial intelligence is making it faster to get drug candidates to the clinic, but to gain a competitive advantage, ...

Following a disappointing readout last year, uniQure on Tuesday posted promising Phase I/II data for its investigational gene ...

Roche’s eye implant Susvimo for patients with neovascular age-related macular degeneration is re-entering the U.S. market ...

The U.K.-based biotech is the latest to cash in on the hot antibody-drug conjugate space, closing a $115.5 million Series A ...

Amylyx Pharmaceuticals announced Wednesday it has acquired a glucagon-like peptide-1 receptor antagonist, avexitide, from ...

House Speaker Mike Johnson (R-La.) on Monday said he intends to have a “significant package of China-related legislation” ...

Life sciences investment firm Flagship Pioneering announced Wednesday that it has raised $3.6 billion with an eye toward ...